JPMorgan Chase & Co’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $617 | Sell |
1,984
-51,923
| -96% | -$16.1K | ﹤0.01% | 5785 |
|
2025
Q1 | $26.4K | Buy |
53,907
+2,357
| +5% | +$1.15K | ﹤0.01% | 5210 |
|
2024
Q4 | $44.1K | Buy |
51,550
+3,237
| +7% | +$2.77K | ﹤0.01% | 5046 |
|
2024
Q3 | $411K | Buy |
48,313
+7,175
| +17% | +$61K | ﹤0.01% | 4133 |
|
2024
Q2 | $192K | Sell |
41,138
-137,786
| -77% | -$643K | ﹤0.01% | 4296 |
|
2024
Q1 | $1.22M | Buy |
178,924
+131,991
| +281% | +$898K | ﹤0.01% | 3444 |
|
2023
Q4 | $157K | Buy |
46,933
+46,545
| +11,996% | +$156K | ﹤0.01% | 4566 |
|
2023
Q3 | $966 | Sell |
388
-26,715
| -99% | -$66.5K | ﹤0.01% | 5691 |
|
2023
Q2 | $34.7K | Sell |
27,103
-48,643
| -64% | -$62.3K | ﹤0.01% | 4936 |
|
2023
Q1 | $61K | Buy |
75,746
+75,358
| +19,422% | +$60.7K | ﹤0.01% | 4837 |
|
2022
Q4 | $0 | Sell |
388
-1,646
| -81% | – | ﹤0.01% | 5550 |
|
2022
Q3 | $2K | Buy |
2,034
+812
| +66% | +$798 | ﹤0.01% | 5311 |
|
2022
Q2 | $1K | Sell |
1,222
-10,328
| -89% | -$8.45K | ﹤0.01% | 5464 |
|
2022
Q1 | $25K | Buy |
11,550
+2,292
| +25% | +$4.96K | ﹤0.01% | 5221 |
|
2021
Q4 | $83K | Buy |
9,258
+487
| +6% | +$4.37K | ﹤0.01% | 4899 |
|
2021
Q3 | $146K | Buy |
8,771
+685
| +8% | +$11.4K | ﹤0.01% | 4544 |
|
2021
Q2 | $168K | Sell |
8,086
-1,434
| -15% | -$29.8K | ﹤0.01% | 4566 |
|
2021
Q1 | $179K | Buy |
9,520
+3,377
| +55% | +$63.5K | ﹤0.01% | 4490 |
|
2020
Q4 | $135K | Buy |
6,143
+1,056
| +21% | +$23.2K | ﹤0.01% | 4244 |
|
2020
Q3 | $103K | Buy |
5,087
+590
| +13% | +$11.9K | ﹤0.01% | 4028 |
|
2020
Q2 | $162K | Buy |
4,497
+1,868
| +71% | +$67.3K | ﹤0.01% | 3760 |
|
2020
Q1 | $86K | Sell |
2,629
-5,789
| -69% | -$189K | ﹤0.01% | 3986 |
|
2019
Q4 | $230K | Buy |
8,418
+7,522
| +840% | +$206K | ﹤0.01% | 3755 |
|
2019
Q3 | $10K | Buy |
+896
| New | +$10K | ﹤0.01% | 4563 |
|